Sientra, Inc. (SIEN): Price and Financial Metrics


Sientra, Inc. (SIEN): $0.52

-0.01 (-2.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SIEN POWR Grades

  • Value is the dimension where SIEN ranks best; there it ranks ahead of 83.48% of US stocks.
  • SIEN's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • SIEN's current lowest rank is in the Sentiment metric (where it is better than 10.7% of US stocks).

SIEN Stock Summary

  • SIENTRA INC's market capitalization of $32,831,069 is ahead of merely 9.92% of US-listed equities.
  • The capital turnover (annual revenue relative to shareholder's equity) for SIEN is 9.83 -- better than 96.61% of US stocks.
  • The volatility of SIENTRA INC's share price is greater than that of 95.74% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SIENTRA INC are ESTA, UCTT, AGRX, PMD, and XERS.
  • SIEN's SEC filings can be seen here. And to visit SIENTRA INC's official web site, go to sientra.com.

SIEN Valuation Summary

  • In comparison to the median Healthcare stock, SIEN's price/earnings ratio is 107.14% lower, now standing at -1.4.
  • SIEN's price/sales ratio has moved down 6 over the prior 96 months.

Below are key valuation metrics over time for SIEN.

Stock Date P/S P/B P/E EV/EBIT
SIEN 2022-09-23 0.4 3.9 -1.4 -5.6
SIEN 2022-09-22 0.4 3.8 -1.4 -5.6
SIEN 2022-09-21 0.4 4.0 -1.4 -5.7
SIEN 2022-09-20 0.4 4.0 -1.4 -5.7
SIEN 2022-09-19 0.4 4.2 -1.5 -5.8
SIEN 2022-09-16 0.4 4.3 -1.6 -5.9

SIEN Growth Metrics

    Its 3 year net income to common stockholders growth rate is now at 71.2%.
  • Its 4 year cash and equivalents growth rate is now at 41.35%.
  • Its 3 year cash and equivalents growth rate is now at -37.24%.
SIEN's revenue has moved up $69,396,000 over the prior 70 months.

The table below shows SIEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 85.179 -58.357 -24.003
2022-03-31 83.769 -47.748 -25.833
2021-12-31 80.683 -42.5 -62.482
2021-09-30 85.603 -36.94 -67.651
2021-06-30 85.2 -28.63 -101.882
2021-03-31 77.545 -45.605 -116.025

SIEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SIEN has a Quality Grade of C, ranking ahead of 28.53% of graded US stocks.
  • SIEN's asset turnover comes in at 0.463 -- ranking 103rd of 186 Medical Equipment stocks.
  • NAOV, NUWE, and ISR are the stocks whose asset turnover ratios are most correlated with SIEN.

The table below shows SIEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.463 0.534 -1.000
2021-03-31 0.425 0.530 -1.073
2020-12-31 0.378 0.547 -0.825
2020-09-30 0.363 0.586 -0.881
2020-06-30 0.360 0.586 -1.192
2020-03-31 0.372 0.599 -1.612

SIEN Price Target

For more insight on analysts targets of SIEN, see our SIEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.29 Average Broker Recommendation 1.12 (Strong Buy)

SIEN Stock Price Chart Interactive Chart >

Price chart for SIEN

SIEN Price/Volume Stats

Current price $0.52 52-week high $6.14
Prev. close $0.53 52-week low $0.51
Day low $0.51 Volume 471,600
Day high $0.55 Avg. volume 704,830
50-day MA $0.80 Dividend yield N/A
200-day MA $1.81 Market Cap 32.83M

Sientra, Inc. (SIEN) Company Bio


Sientra Inc. develops and sells medical aesthetics products to plastic surgeons in the United States. The company was founded in 2003 and is based in Santa Barbara, California.


SIEN Latest News Stream


Event/Time News Detail
Loading, please wait...

SIEN Latest Social Stream


Loading social stream, please wait...

View Full SIEN Social Stream

Latest SIEN News From Around the Web

Below are the latest news stories about SIENTRA INC that investors may wish to consider to help them evaluate SIEN as an investment opportunity.

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

Saudi Food & Drug Authority approval propels Sientra international expansion into the GCC and Middle East regionSANTA BARBARA, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received approval from the Saudi Food & Drug Authority to market the Company’s line of smooth surface, High-Strength Cohesive (HSC and HSC+) silic

Yahoo | September 20, 2022

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SANTA BARBARA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on August 29, 2022, the Company approved equity award grants under the Sientra Inc. Inducement Plan to 49 new employees. The new employees were granted restricted stock units representing a total of 1,182,029 shares of common stock. The restricted stock units will vest in time-based installments

Yahoo | September 6, 2022

Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel

SANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the second quarter that ended June 30, 2022. Q2 2022 Financial and Business Highlights Net sales of $21.5 million, representing growth of 7% over the second quarter of 2021, driven by 23% year-over-year growth in reconstruction.Year-to-date net

Yahoo | August 11, 2022

7 Stocks Due for a Stunning Short Squeeze

If you have the inclination and the iron stomach for wild volatility, these intriguing short-squeeze stocks might be up your alley.

Josh Enomoto on InvestorPlace | August 9, 2022

Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022

SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the second quarter of 2022 after the close of trading on Thursday, August 11, 2022. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time. The dial-in numbers are 1-866-374-5140

Yahoo | July 28, 2022

Read More 'SIEN' Stories Here

SIEN Price Returns

1-mo -20.70%
3-mo -37.90%
6-mo -76.58%
1-year -90.83%
3-year -92.06%
5-year -96.62%
YTD -85.83%
2021 -5.66%
2020 -56.49%
2019 -29.66%
2018 -9.60%
2017 65.02%

Continue Researching SIEN

Here are a few links from around the web to help you further your research on Sientra Inc's stock as an investment opportunity:

Sientra Inc (SIEN) Stock Price | Nasdaq
Sientra Inc (SIEN) Stock Quote, History and News - Yahoo Finance
Sientra Inc (SIEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7204 seconds.